Intravascular thrombosis after exsanguination in a patient treated with epsilon-aminocaproic acid.

[1]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[2]  D. Jordan,et al.  Prophylactic epsilon-Aminocaproic Acid (EACA) Administration Minimizes Blood Replacement Therapy During Cardiac Surgery , 1995, Anesthesia and analgesia.

[3]  W. van Oeveren,et al.  Procoagulant triggers during cardiopulmonary bypass. , 1995, Blood.

[4]  L. Eijsman,et al.  Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting. , 1995, The Annals of thoracic surgery.

[5]  C. Naylor,et al.  Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding. , 1994, The Annals of thoracic surgery.

[6]  G. Laub,et al.  The impact of aprotinin on coronary artery bypass graft patency. , 1994, Chest.

[7]  J. Murkin.  Con: tranexamic acid is not better than aprotinin in decreasing bleeding after cardiac surgery. , 1994, Journal of cardiothoracic and vascular anesthesia.

[8]  R. Adamson,et al.  Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting , 1994 .

[9]  R. Adamson,et al.  Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. , 1994, The Journal of thoracic and cardiovascular surgery.

[10]  M. Spannagl,et al.  High Dose Aprotinin Reduces Prothrombin and Fibrinogen Conversion in Patients Undergoing Extracorporeal Circulation for Myocardial Revascularization , 1994, Thrombosis and Haemostasis.

[11]  R. Emery,et al.  Decreased postoperative drainage with addition of ϵ-aminocaproic acid before cardiopulmonary bypass , 1994 .

[12]  F. Camu,et al.  Intraoperative coronary thrombosis: can aprotinin and protamine be incriminated? , 1994, Journal of cardiothoracic and vascular anesthesia.

[13]  D. Royston.  Intraoperative coronary thrombosis: can aprotinin be incriminated? , 1994, Journal of cardiothoracic and vascular anesthesia.

[14]  C. Tatooles,et al.  Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. A multicenter, randomized, double-blind, placebo-controlled study. , 1994, The Journal of thoracic and cardiovascular surgery.

[15]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments] , 1993 .

[16]  N. Tabuchi,et al.  Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass , 1993 .

[17]  F. Loop,et al.  Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. , 1992, The Annals of thoracic surgery.

[18]  J. Desroches,et al.  Natural and synthetic antifibrinolytics in cardiac surgery , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[19]  L. Cregler.  Antithrombotic therapy in left ventricular thrombosis and systemic embolism. , 1992, American heart journal.

[20]  R. Hart,et al.  Cardiogenic stroke in the elderly. , 1991, Clinics in Geriatric Medicine.

[21]  M. Jochum,et al.  Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. , 1990, Anesthesiology.

[22]  I. Goel,et al.  Prophylactic tranexamic acid decreases bleeding after cardiac operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[23]  R. Colman,et al.  Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III , 1985 .